Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial

  1. Salvador Bofill, J.
  2. Moreno Anton, F.
  3. Rodriguez Sanchez, C.A.
  4. Galve Calvo, E.
  5. Hernando Melia, C.
  6. Ciruelos Gil, E.M.
  7. Vidal, M.
  8. Jiménez-Rodriguez, B.
  9. De la Cruz Merino, L.
  10. Martínez Jañez, N.
  11. Villanueva Vazquez, R.
  12. de Toro Salas, R.
  13. Anton Torres, A.
  14. Alvarez Lopez, I.M.
  15. Gavila Gregori, J.
  16. Quiroga Garcia, V.
  17. Vicente Rubio, E.
  18. De la Haba-Rodriguez, J.
  19. Gonzalez-Santiago, S.
  20. Diaz Fernandez, N.
  21. Barnadas Molins, A.
  22. Cantos Sanchez de Ibargüen, B.
  23. Delgado Mingorance, J.I.
  24. Bellet Ezquerra, M.
  25. de Casa, S.
  26. Gimeno, A.
  27. Martin, M.
  28. Montrer des auteurs +
Revue:
Breast

ISSN: 1532-3080 0960-9776

Année de publication: 2022

Volumen: 66

Pages: 77-84

Type: Article

DOI: 10.1016/J.BREAST.2022.09.006 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable